SUTRO BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $387.2M
Liabilities Breakdown FY2024
Total Liabilities: $342.6M
Asset Breakdown
Total Assets: $387.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $190.3M | 49.1% |
| Accounts Receivable | $8.6M | 2.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $18.2M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $170.1M | 43.9% |
Liabilities Breakdown
Total Liabilities: $342.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.5M | 3.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $332.1M | 96.9% |